BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9733054)

  • 1. Phase-II randomized study of pre-operative IL-2 administration in operable NSCLC.
    Masotti A; Morandini G; Ortolani R; Fumagalli L
    Lung Cancer; 1998 Jun; 20(3):191-202. PubMed ID: 9733054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Piacentini MG; Franciosi C; Caprotti R; De Fina S; Cesana G; Uggeri F; Conti M; Uggeri F
    Hepatogastroenterology; 2004; 51(60):1872-6. PubMed ID: 15532847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
    J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical surgery does not recover immunodeficiency associated with gastric cancer.
    Romano F; Caprotti R; Bravo AF; Conti M; Colombo G; Piacentini G; Uggeri F; Uggeri F
    J Exp Clin Cancer Res; 2003 Jun; 22(2):179-83. PubMed ID: 12866567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase IB study on prevention of surgery-induced immunodeficiency with preoperative administration of low-dose subcutaneous interleukin-2 in gastric cancer patients.
    Cerea K; Romano F; Bravo AF; Motta V; Uggeri F; Brivio F; Fumagalli LA; Uggeri F
    J Surg Oncol; 2001 Sep; 78(1):32-7. PubMed ID: 11519066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Pembrolizumab on T Lymphocyte Subsets in Patients with Advanced 
Non-small Cell Lung Cancer and Its Therapeutic Effect].
    Wang Y; Wang Y; Jiang M; Zhao Y; Zhang X
    Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):182-187. PubMed ID: 33819968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter phase 2 study of interleukin-2 and 13-cis retinoic acid as maintenance therapy in advanced non-small-cell lung cancer.
    Recchia F; Saggio G; Nuzzo A; Biondi E; Di Blasio A; Cesta A; Candeloro G; Alesse E; Rea S
    J Immunother; 2006; 29(1):87-94. PubMed ID: 16365604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of interleukin-2 and 13-cis-retinoic acid as maintenance therapy in metastatic colorectal cancer.
    Recchia F; Saggio G; Cesta A; Candeloro G; Di Blasio A; Amiconi G; Lombardo M; Nuzzo A; Lalli A; Alesse E; Necozione S; Rea S
    Cancer Immunol Immunother; 2007 May; 56(5):699-708. PubMed ID: 16955297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocytic subpopulation changes after open and laparoscopic cholecystectomy: a prospective and comparative study on 38 patients.
    Cristaldi M; Rovati M; Elli M; Gerlinzani S; Lesma A; Balzarotti L; Taschieri AM
    Surg Laparosc Endosc; 1997 Jun; 7(3):255-61. PubMed ID: 9194291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.
    Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M
    Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers.
    Romano F; Uggeri F; Crippa S; Di Stefano G; Scotti M; Scaini A; Caprotti R; Uggeri F
    J Exp Clin Cancer Res; 2004 Jun; 23(2):195-200. PubMed ID: 15354402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 1 trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus-infected patients with 100-500 CD4 cells/microL.
    Jacobson MA; Hardy D; Connick E; Watson J; DeBruin M
    J Infect Dis; 2000 Oct; 182(4):1070-6. PubMed ID: 10979901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological consequences of interleukin 12 administration after autologous stem cell transplantation.
    Pelloso D; Cyran K; Timmons L; Williams BT; Robertson MJ
    Clin Cancer Res; 2004 Mar; 10(6):1935-42. PubMed ID: 15041709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The preoperative administration of lentinan ameliorated the impairment of natural killer activity after cardiopulmonary bypass.
    Hamano K; Gohra H; Katoh T; Fujimura Y; Zempo N; Esato K
    Int J Immunopharmacol; 1999 Aug; 21(8):531-40. PubMed ID: 10458542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy.
    Recchia F; Saggio G; Cesta A; Alesse E; Gallo R; Necozione S; Rea S
    Anticancer Res; 2005; 25(4):3149-57. PubMed ID: 16080579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.
    Sereti I; Dunham RM; Spritzler J; Aga E; Proschan MA; Medvik K; Battaglia CA; Landay AL; Pahwa S; Fischl MA; Asmuth DM; Tenorio AR; Altman JD; Fox L; Moir S; Malaspina A; Morre M; Buffet R; Silvestri G; Lederman MM;
    Blood; 2009 Jun; 113(25):6304-14. PubMed ID: 19380868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of auxiliary therapy with Danggui Buxue Decoction No.1 in treating patients of non-small cell lung cancer at peri-operational stage.
    Du QC; Yang KZ; Sun XF
    Chin J Integr Med; 2009 Jun; 15(3):184-8. PubMed ID: 19568710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a preoperative therapy with interleukin-2 on surgery-induced lymphocytopenia in cancer patients.
    Brivio F; Lissoni P; Tisi E; Erba L; Barni S; Tancini G; Rescaldani R; Alderi G; Nociti V
    Oncology; 1992; 49(3):215-8. PubMed ID: 1495748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC).
    Pachynski RK; Morishima C; Szmulewitz R; Harshman L; Appleman L; Monk P; Bitting RL; Kucuk O; Millard F; Seigne JD; Fling SP; Maecker HT; Duault C; Ramchurren N; Hess B; D'Amico L; Lacroix A; Kaiser JC; Morre M; Grégoire A; Cheever M; Yu EY; Fong L
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Quantitative and Functional Changes of Postoperative Peripheral Blood Immune Cell Subsets Relate to Prognosis of Patients with Subarachnoid Hemorrhage: A Preliminary Study.
    Zhou Y; Jiang Y; Peng Y; Zhang M
    World Neurosurg; 2017 Dec; 108():206-215. PubMed ID: 28866066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.